Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

Study on Liver Fibrosis Assessment Using 68Ga-FAPI-46 Imaging in Patients with Suspected or Confirmed Nonalcoholic Steatohepatitis

Recruiting

2 1 1
Investigated drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Recruiting

3 1
Investigated diseases:
- Hepatic fibrosis
Investigated drugs:
- Efruxifermin
Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Recruiting

3 1
Investigated drugs:
- Efruxifermin
Study of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Recruiting

2 1
Investigated drugs:
- Namodenoson
Safety and Tolerability of Efimosfermin Alfa in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Not yet recruiting

3 1

+3
Phase 3 Randomized Study of Efimosfermin Alfa for Safety and Efficacy in Adults with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Not yet recruiting

3 1

+3
Study of Fecal Microbiota Capsules for Treating Non-Alcoholic Steatohepatitis in Patients

Not yet recruiting

2 1
Investigated drugs:
- Allogeneic Faecal Microbiota, Pooled
Study on Empagliflozin for Patients with Non-Alcoholic Steatohepatitis (NASH)

Not yet recruiting

3 1 1 1
Investigated diseases:
- Metabolic dysfunction-associated steatohepatitis
Investigated drugs:
- Empagliflozin
Study on Efinopegdutide for Adults with Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis

Not recruiting

2 1
Investigated drugs:
- Efinopegdutide
Study on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3

Not recruiting

3 1
Investigated drugs:
- Lanifibranor
+5

Find clinical trials in your area

Matched clinical trials

We use cookies